SCOTUS: Supreme Court Lifts Biosimilars by Allowing Early Commercial Marketing Notice

SCOTUS: Supreme Court Lifts Biosimilars by Allowing Early Commercial Marketing Notice


The Supreme Court handed down its opinion in Sandoz Inc. v. Amgen Inc. , marking the first time the Court has interpreted the Biologics Price Competition and Innovation Act for the approval of biosimilar drugs.



from Biotech News